This application is for a competitive renewal and transformation of the HMO Cancer Research Network (CRN) into a research resource. The CRN, which has been continuously funded since 1999, provides infrastructure support to conduct cancer research in the setting of not-for-profit integrated health care delivery systems. The setting has advantages for conducting population sciences research that collectively result in a unique, unparalleled resource for conducting epidemiologic and health services research in cancer. These advantages include externally-funded research groups with investigators with expertise in conducting public-domain cancer research in these settings;defined populations with a combined membership of over 10 million individuals for whom health care is provided;clinical and administrative data systems that capture most aspects of care;development and implementation of common data models in the Virtual Data Warehouse (VDW) to facilitate collaborative and multi-institutional research;and access to clinicians and administrators to facilitate translation of research findings to practice. We plan to enhance the CRN in several areas, including: Establishing an Informatics Core focused on continual improvement of the VDW through implementation of distributed query tools to facilitate preparatory-to-research and collaborative research studies, and improvement of existing and implementation of new VDW domains of relevance to cancer research;identification and promotion of research in strategic areas for which the CRN is uniquely positioned (i.e., Prevention &Screening;Treatment &Outcomes;Biospecimens &Molecular Applications;Communications &Decision-Making;Health Care Quality &Cost;and Dissemination &Implementation);institutionalizing a CRN Scholars mentored career development program for junior investigators;continuation of a Developmental and Pilot Studies Program to support pilot studies and to enhance infrastructure;and implementation of an Outreach and External Collaborations Core to facilitate research collaborations. This continued infrastructure support will enable and facilitate researchers'continued access to large integrated delivery systems and motivate continued evolution as the nation's premier learning healthcare systems.

Public Health Relevance

This application for the Cancer Research Network supports activities that enhance the ability to conduct impactful, relevant cancer research in integrated health care systems that provide health care to over 10 million members. Activities include data resource enhancement, career development of junior investigators, funding of promising pilot studies, and promotion of collaborations among research scientists.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-B (M2))
Program Officer
Grauman, Alyssa
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Kaiser Foundation Research Institute
United States
Zip Code
Jensen, Christopher D; Doubeni, Chyke A; Quinn, Virginia P et al. (2015) Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol 13:739-46
Lee, Jeffrey K; Liles, Elizabeth G; Bent, Stephen et al. (2014) Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 160:171
Corley, Douglas A; Jensen, Christopher D; Marks, Amy R et al. (2014) Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370:1298-306
Feigelson, Heather Spencer; Zeng, Chan; Pawloski, Pamala A et al. (2014) Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample. PLoS One 9:e94977
Hillyer, Grace Clarke; Schmitt, Karen M; Freedberg, Daniel E et al. (2014) Fecal-based colorectal cancer screening among the uninsured in northern Manhattan. Am J Prev Med 47:182-7